Best The Lancet Respiratory Medicine Podcasts (2025)

1
Hjalmar Bouma on sepsis in patients who are immunocompromised 13:33

10d ago13:33

13:33

Bianca Brandon, Senior Editor at The Lancet Respiratory Medicine, is joined by Professor Hjalmar Bouma to discuss a new review on sepsis in immunocompromised patients, exploring the diagnostic challenges, complexities of immune status, and future directions for targeted therapies. The episode also analyses the increased vulnerability of specific pa…

1
In conversation with... Hjalmar Bouma 13:33

11d ago13:33

13:33

Bianca Brandon, Senior Editor at The Lancet Respiratory Medicine, is joined by Professor Hjalmar Bouma to discuss a new review on sepsis in immunocompromised patients, exploring the diagnostic challenges, complexities of immune status, and future directions for targeted therapies.By The Lancet

1
Hydrocortisone for Severe Pneumonia (REMAP-CAP), Intensive BP Control in Diabetes (BPROAD), Aldosterone Synthase Inhibitors for Hypertension (ADVANCE-HTN), Reduced-dose Apixaban for Cancer Associated Thrombosis ... 56:43

1M ago56:43

56:43

What do you do when most trials suggest benefit for an intervention, but then a new trial suggests harm? We thought steroids in pneumonia was a settled question, but REMAP-CAP had other plans! We also review a new RCT for BP targets in patients with hypertension and diabetes, a new aldosterone synthase inhibitor for hypertension, and reduced dose a…

1
In conversation with... Simon Wolf 11:47

2M ago11:47

11:47

Deputy Editor of The Lancet Respiratory Medicine Ari Colosio discusses the critical findings of a new epidemiological study on pulmonary embolism in children and adolescents with Simon Wolf from the University Hospital of Zurich.By The Lancet

1
Simon Wolf on pulmonary embolism in children and adolescents in the US during 2016 and 2019 11:47

2M ago11:47

11:47

Deputy Editor of The Lancet Respiratory Medicine Ari Colosio discusses the critical findings of a new epidemiological study on pulmonary embolism in children and adolescents with Simon Wolf from the University Hospital of Zurich. This episode delves into the prevalence, risk factors, and clinical implications of this rare but serious condition, hig…

1
Half Dose DOAC for Long Term VTE Prevention, Biomarker Guided Antibiotics for Sepsis, GPT-4 Assistance for Physicians, Optimal Vasopressin Initiation for Shock, DOAC vs No AC for A fib After Intracerebral ... 1:32:52

2M ago1:32:52

1:32:52

For this episode we are joined by EBM guru, Dr. Brian Locke, who deftly breaks down all of our statistics questions. Is half dose DOAC as good as full dose DOAC for preventing VTE, and does it reduce bleeding risk? Can procalcitonin reduce duration of antibiotics for infections without compromising mortality rates? Can LLMs like GPT-4 help physicia…

1
In conversation with... Sandeep Sahay and Franck Rahaghi 14:53

3M ago14:53

14:53

Dr Sandeep Sahay and Professor Franck Rahaghi discuss their Personal View on future treatment paradigms in pulmonary arterial hypertension.By The Lancet

1
Sandeep Sahay and Franck Rahaghi on future treatment paradigms in pulmonary arterial hypertension 14:53

3M ago14:53

14:53

Dr Sandeep Sahay and Professor Franck Rahaghi discuss their Personal View on future treatment paradigms in pulmonary arterial hypertension. Read the full paper, Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients, here: https://www.thelancet.com/journals/lanres/article/PII…

1
7 vs 14 Days of Antibiotics for Bacteremia, Factor XI Inhibition for Atrial Fibrillation, ACEi or ARB Before Elective Surgery, GLP-1 Agonist for HFpEF and Obesity 1:06:04

4M ago1:06:04

1:06:04

We're back, after a brief hiatus! Today we talk about duration of therapy for bacteremia, Factor XI inhibition for atrial fibrillation, whether to stop ACEi or ARB before elective surgery, and whether GLP-1 agonists are beneficial in heart failure with preserved ejection fraction. Go to minute 7:30 to skip the banter. 7 vs 14 Days of Antibiotics fo…

1
Sergio Harari sul trattamento della linfangioleiomiomatosi (LAM) (in Italian) 10:40

7M ago10:40

10:40

Il Professor Sergio Harari commenta i risultati di un trial clinico di fase 2 volto a valutare l’attivita’ e la sicurezza del farmaco nintedanib come trattamento in pazienti affetti da linfangioleiomiomatosi (LAM). Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https:/…

1
Sergio Harari on the treatment of lymphangioleiomyomatosis (LAM) 10:26

7M ago10:26

10:26

Professor Sergio Harari joins us to discuss the results of a phase 2 clinical trial evaluating activity and safety of nintedanib in people with lymphangioleiomyomatosis (LAM). Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal h…

1
In conversation with... Sergio Harari 10:26

7M ago10:26

10:26

Professor Sergio Harari joins us to discuss the results of a phase 2 clinical trial evaluating activity and safety of nintedanib in people with lymphangioleiomyomatosis (LAM).By The Lancet

1
In conversation with... Sergio Harari (in Italian) 10:40

7M ago10:40

10:40

Il Professor Sergio Harari commenta i risultati di un trial clinico di fase 2 volto a valutare l’attivita’ e la sicurezza del farmaco nintedanib come trattamento in pazienti affetti da linfangioleiomiomatosi (LAM).By The Lancet

1
In conversation with... Robert Kullberg 12:06

8M ago12:06

12:06

Dr Robert Kullberg joins us to discuss his Viewpoint on empiric antibiotic therapy for sepsis and the importance of reducing unnecessary use of anti-anaerobic antibiotics.By The Lancet

1
Robert Kullberg on empirical antibiotics for Sepsis 12:06

8M ago12:06

12:06

Dr Robert Kullberg joins us to discuss his Viewpoint on empiric antibiotic therapy for sepsis and the importance of reducing unnecessary use of anti-anaerobic antibiotics. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00257-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanres Continue this conversation …

1
Anticoagulation in AF with Cirrhosis, Trends in Anticoagulation for Acute PE, Beta Blockers for Acute MI with Normal EF, Finerenone for HFpEF, Continuous vs Intermittent Infusion for Antibiotics, Cefepime ... 1:05:23

8M ago1:05:23

1:05:23

It's been a long time, but we are back! Apologies on the audio quality from Dr. Jenkins. Apparently he was recording from inside a cardboard box. Today we talk about important, practice changing studies in internal medicine from the last several months. What's the best anticoagulant in patients with cirrhosis and atrial fibrillation? Why do doctors…

1
Heather Zar on early-life RSV disease and long-term respiratory health 19:07

9M ago19:07

19:07

Professor Heather Zar joins The Lancet Respiratory Medicine to discuss early-life RSV disease and long-term respiratory health. This topic will be covered in one of four Series papers in a cross-journal Series with The Lancet. You can read the Series of papers at: https://www.thelancet.com/series/respiratory-syncytial-virus?dgcid=buzzsprout_icw_pod…

1
In conversation with... Heather Zar 19:07

9M ago19:07

19:07

Professor Heather Zar joins The Lancet Respiratory Medicine to discuss early-life RSV disease and long-term respiratory health. This topic will be covered in one of four Series papers in a cross-journal Series with The Lancet.By The Lancet

1
In conversation with... Margaux Mesle 10:25

10M ago10:25

10:25

Dr Margaux Mesle discusses estimates of lives directly saved by COVID-19 vaccination programs in the WHO European Region in the period from 2020 to 2023 and public health implications.By The Lancet

1
Margaux Mesle on lives saved by COVID-19 vaccination 10:21

10M ago10:21

10:21

Dr Margaux Mesle discusses estimates of lives directly saved by COVID-19 vaccination programs in the WHO European Region in the period from 2020 to 2023 and public health implications. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00179-6?dgcid=buzzsprout_icw_podcast_generic_lanres Continue this conversat…

1
In conversation with... James Hull 11:04

10M ago11:04

11:04

Professor James Hull joins us to discuss his recent Spotlight on protecting the respiratory health of athletes ahead of the Summer Olympics and Paralympics.By The Lancet

1
James Hull on protecting the respiratory health of athletes 11:04

10M ago11:04

11:04

Professor James Hull joins us to discuss his recent Spotlight on protecting the respiratory health of athletes ahead of the Summer Olympics and Paralympics. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00183-8?dgcid=buzzsprout_icw_podcast_generic_lanres Continue this conversation on social! Follow us tod…

1
In conversation with... Eric Lim 6:17

1y ago6:17

6:17

Professor Eric Lim discusses the outcomes after extended pleurectomy decortication plus chemotherapy versus chemotherapy alone for pleural mesothelioma.By The Lancet

1
Eric Lim on treatments for pleural mesothelioma 6:17

1y ago6:17

6:17

Professor Eric Lim discusses the outcomes after extended pleurectomy decortication plus chemotherapy versus chemotherapy alone for pleural mesothelioma. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/com…

1
In conversation with... Anne Chang 9:49

1y ago9:49

9:49

Dr Anne Chang discusses the burden of chronic respiratory diseases in Indigenous people.By The Lancet

1
Anne Chang on the burden of chronic respiratory diseases in Indigenous people 9:49

1y ago9:49

9:49

Dr Anne Chang discusses the burden of chronic respiratory diseases in Indigenous people. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00008-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanres Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.c…

1
Daniel Steinfort and Shankar Siva on radiotherapy field planning in patients with NSCLC 10:23

1y ago10:23

10:23

Professor Daniel Steinfort and Professor Shankar Siva discuss the effect of systematic endoscopic mediastinal staging on radiotherapy field planning in patients with locally advanced non-small-cell lung cancer. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://fac…

1
In conversation with... Daniel Steinfort and Shankar Siva 10:23

1y ago10:23

10:23

Professor Daniel Steinfort and Professor Shankar Siva discuss the effect of systematic endoscopic mediastinal staging on radiotherapy field planning in patients with locally advanced non-small-cell lung cancer.By The Lancet

1
In conversation with... Daniel Prieto-Alhambra, Annika Jödicke, and Martí Català 8:16

1+ y ago8:16

8:16

Prof Daniel Prieto-Alhambra, Dr Annika Jödicke, and Dr Martí Català discuss the effectiveness of COVID-19 vaccines to prevent Long COVID, estimated to affect up to 20% of those infected with SARS-CoV-2.By The Lancet

1
Daniel Prieto-Alhambra, Annika Jödicke, and Martí Català on vaccination to prevent Long COVID 8:16

1+ y ago8:16

8:16

Prof Daniel Prieto-Alhambra, Dr Annika Jödicke, and Dr Martí Català discuss the effectiveness of COVID-19 vaccines to prevent Long COVID, estimated to affect up to 20% of those infected with SARS-CoV-2. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00414-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lan…

1
In conversation with... Sarah Gorst and Tim Nicholson 15:32

1+ y ago15:32

15:32

Dr Tim Nicholson and Dr Sarah Gorst discuss the development of an international Delphi consensus study on a core outcome measurement set for long COVID and how it will be used to inform future research and clinical care.By The Lancet

1
Sarah Gorst and Tim Nicholson on long COVID outcomes 15:32

1+ y ago15:32

15:32

Dr Tim Nicholson and Dr Sarah Gorst discuss the development of an international Delphi consensus study on a core outcome measurement set for long COVID and how it will be used to inform future research and clinical care. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup h…

1
In conversation with... Betty Raman 12:02

1+ y ago12:02

12:02

Dr Betty Raman discusses multiorgan MRI findings in patients after hospitalisation with COVID-19.By The Lancet

1
Betty Raman on multiorgan MRI abnormalities after hospitalisation with COVID-19 12:02

1+ y ago12:02

12:02

Dr Betty Raman discusses multiorgan MRI findings in patients after hospitalisation with COVID-19. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00262-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanres Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://in…

1
In conversation with... Keith Chappell 8:13

1+ y ago8:13

8:13

Dr Keith Chappell discusses the bivalent recombinant vaccine for COVID-19 following the study by Dayan and colleagues, with focus on vaccine access, variants and boosters, tolerability and side effects, as well as hopes for future trials.By The Lancet

1
Keith Chappell on a bivalent recombinant vaccine for COVID-19 8:13

1+ y ago8:13

8:13

Dr Keith Chappell discusses the bivalent recombinant vaccine for COVID-19 following the study by Dayan and colleagues, with focus on vaccine access, variants and boosters, tolerability and side effects, as well as hopes for future trials. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.co…

1
Metformin and Long COVID, Central Lines and Thrombocytopenia, DOACs vs LMWH in Cancer Associated Thrombosis, Early vs Late Anticoagulation after Stroke with Atrial Fibrillation 59:11

2y ago59:11

59:11

Today we are joined by Dr. Brian Locke, recently graduated pulmonary-critical care fellow, who takes us on a journey of avoiding statistical fallacies. Does metformin reduce the likelihood of long COVID? Should we give platelet transfusions to thrombocytopenic patients before central line placement? Did the CANVAS trial change practice in cancer as…

1
Osmotic Demyelination Syndrome and Hyponatremia with Dr. Joel Topf, Apixaban vs Warfarin for On-X Aortic Valve, Perioperative Blood Pressure Strategies, Diagnostic Accuracy of CT Abdomen Without Contrast ... 1:08:12

2y ago1:08:12

1:08:12

Today we have a special guest, Dr. Joel Topf, board-certified nephrologist and medical educator extraordinaire. Our listeners will likely recognize Dr. Topf from his prolific tweeting @Kidney_boy, as well as his numerous appearances on the Curbsiders podcast. He is a co-founder of the NephJC on Twitter, and host and founder of the NephJC podcast Fr…

1
Doxycycline Post-Exposure Prophylaxis for STIs (DoxyPEP), High Dose Prophylactic Anticoagulation for COVID-19 (ANTICOVID), Rates of Fracture Non-union and Bisphosphonates 46:57

2y ago46:57

46:57

This week we have special guest, Dr. Adam Spivak, to talk about the new study on doxycycline post-exposure prophylaxis for STIs. Dr. Spivak is an infectious disease expert and works in both an HIV clinic and a free PrEP clinic. I also review the latest COVID-19 anticoagulation trial and a paper looking at rates of fracture non-union in people who r…

1
In conversation with... James Chalmers 11:57

2y ago11:57

11:57

Prof. James Chalmers discusses the characteristics of patients with bronchiectasis across Europe, the differences between countries, and possible differences in clinical outcomes, based on data from the EMBARC registry.By The Lancet

1
James Chalmers on bronchiectasis across Europe 11:57

2y ago11:57

11:57

Prof. James Chalmers discusses the characteristics of patients with bronchiectasis across Europe, the differences between countries, and possible differences in clinical outcomes, based on data from the EMBARC registry. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00093-0/fulltext?dgcid=buzzsprout_tlv_ep…

1
Thiazides for Kidney Stones, Hydrocortisone for Severe Pneumonia (CAPE COD), 2023 GOLD COPD Guidelines, Real World Use of Oral Antibiotics for Infective Endocarditis 1:19:31

2y ago1:19:31

1:19:31

Today we have special guest, Dr. Sarah Gilligan, a nephrologist, to talk about the new study of thiazides for kidney stones. We all learn in medical school that thiazides reduce urinary excretion of calcium, but does that really translate to fewer kidney stones? We also have Dr. Brian Locke on to talk about the CAPE COD trial, a big new critical ca…

1
In conversation with... Richard Costello 11:38

2y ago11:38

11:38

Prof Richard Costello discusses the use of digital measurements of medication adherence and lung function to guide management of uncontrolled asthma.By The Lancet

1
Richard Costello on management of uncontrolled asthma 11:38

2y ago11:38

11:38

Prof Richard Costello discusses the use of digital measurements of medication adherence and lung function to guide management of uncontrolled asthma. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/compan…

1
In conversation with... Keiju Aokage 5:51

2y ago5:51

5:51

Dr Keiju Aokage discusses segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less.By The Lancet

1
Keiju Aokage on segmentectomy for ground-glass-dominant lung cancer 5:51

2y ago5:51

5:51

Dr Keiju Aokage discusses segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less. Read the full article: Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial Continue this conver…

1
Antibiotic Duration for Febrile UTI in Males, Lower GI Bleeding Guidelines, Intravenous Contrast in Patients with Acute Kidney Injury 45:58

2+ y ago45:58

45:58

Today we welcome special guest and fellow EBM lover Dr. Mita Hoppenfeld to talk about a new randomized controlled trial evaluating the best duration of antibiotics for febrile UTI in men. Is 7 days as good as 14 days? We also review the latest guidelines for lower GI bleeding and a new retrospective study on renal outcomes in patients with AKI who …

1
In conversation with... Carol Hodgson 19:16

2+ y ago19:16

19:16

Carol Hodgson discusses recent advances in our understanding of in-hospital and post-discharge outcomes in critically ill patients who receive ECMO.By The Lancet

1
Carol Hodgson on post-discharge outcomes for ECMO patients 19:16

2+ y ago19:16

19:16

Carol Hodgson discusses recent advances in our understanding of in-hospital and post-discharge outcomes in critically ill patients who receive ECMO. Read the full article: Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES) Co…

1
Early Vasopressors and Restrictive Fluids in Septic Shock (CLOVERS), Furosemide vs Torsemide in Heart Failure (TRANSFORM-HF), Aspirin vs Enoxaparin after Extremity Fracture (PREVENT CLOT), Haloperidol ... 51:05

2+ y ago51:05

51:05

We're back with Season 4! Sorry for the unplanned hiatus. Today we talk about the CLOVERS trial, which tested the hypothesis that early vasopressors and restrictive fluid would be superior to liberal fluids plus rescue vasopressors. We also looked at the TRANSFORM-HF study, which compared torsemide and furosemide in congestive heart failure, the PR…

Podcasts Worth a Listen

The Lancet Respiratory Medicine Podcasts

Podcasts Worth a Listen

Quick Reference Guide